12 Health Care Stocks Moving In Tuesday's Intraday Session
Femasys Inc FEMY
$2.86
▼ -1.72%
($-0.05)
🗓️ Earnings Next Week
Open
$2.91
Prev Close
$2.91
Day Range
$2.81 – $3.02
52W Range
$2.64 – $22.20
Market Cap
$8.64M
Beta
-2.16
EPS (TTM)
$-0.31
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-18 |
| Shares Out. | 3,020,000 |
| Website | femasys.com/ ↗ |
| Phone | 18004831140 |
| Employees | 54 |
| Revenue | $424,889 |
| Gross Profit | $266,283 |
| Net Income | $846,100 |
| Free Cash Flow | -$18.6M |
| Total Assets | $16.5M |
| Total Liabilities | $9.2M |
| Equity | $7.3M |
About Femasys Inc
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Femasys Inc is a publicly traded company under the ticker symbol FEMY on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)